Lipocine (LPCN) Asset Utilization Ratio (2018 - 2025)
Lipocine's Asset Utilization Ratio history spans 8 years, with the latest figure at 0.25 for Q3 2025.
- For Q3 2025, Asset Utilization Ratio fell 27.17% year-over-year to 0.25; the TTM value through Sep 2025 reached 0.25, down 27.17%, while the annual FY2024 figure was 0.49, 422.55% up from the prior year.
- Asset Utilization Ratio reached 0.25 in Q3 2025 per LPCN's latest filing, up from 0.22 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.52 in Q4 2024 to a low of 0.01 in Q1 2021.
- Average Asset Utilization Ratio over 5 years is 0.21, with a median of 0.22 recorded in 2025.
- Peak YoY movement for Asset Utilization Ratio: crashed 502.57% in 2021, then skyrocketed 25579.05% in 2024.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.34 in 2021, then crashed by 96.23% to 0.01 in 2022, then skyrocketed by 854.42% to 0.12 in 2023, then soared by 317.99% to 0.52 in 2024, then plummeted by 51.86% to 0.25 in 2025.
- Per Business Quant, the three most recent readings for LPCN's Asset Utilization Ratio are 0.25 (Q3 2025), 0.22 (Q2 2025), and 0.17 (Q1 2025).